Companies / BOC Sciences / Olokizumab
BOC Sciences

Olokizumab | BOC Sciences

Olokizumab is a humanized monoclonal antibody that targets interleukin-6. Olokizumab is effective in the treatment of rheumatoid arthritis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.